20 results
8-K
EX-3.1
PRME
Prime Medicine, Inc.
21 May 24
Amendments to Articles of Incorporation or Bylaws
4:03pm
to such Proceeding; (d) “Expenses” means all attorneys’ fees, retainers, court costs, transcript costs, fees of expert witnesses, private investigators
PRE 14A
PRME
Prime Medicine, Inc.
19 Apr 24
Preliminary proxy
4:07pm
qualifies as an “audit committee financial expert” within the meaning of applicable SEC regulations. In making this determination, our Board … Governance Guidelines. Further, our Board has determined that Michael Kelly is an audit committee financial expert as defined by the rules of the SEC
8-K
EX-99.1
PRME
Prime Medicine, Inc.
8 Jan 24
Regulation FD Disclosure
8:01am
the potential of Prime Editing Hematology & Business Liver Ocular Neuromuscular Immunology Development Strong company foundation Expert at designing guide RNAs
DEF 14A
3ry3szd
28 Apr 23
Definitive proxy
8:34am
8-K
EX-3.2
7g12mvq
24 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:41pm
S-1/A
EX-10.1
ssnmmf bj
13 Oct 22
IPO registration (amended)
10:51am
S-1
EX-3.3
bpio4g
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.1
b8rw1 hgn0flg9j9wv
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.6
7m5n mb9c3octy9oe51
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.13
82mtk3svro m7v
23 Sep 22
IPO registration
4:12pm
S-1
EX-3.4
7xhye
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.7
ypjb 5a2zx2l4
23 Sep 22
IPO registration
4:12pm
DRS/A
EX-3.4
k2xv 7qym069157w2oaj
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.6
la7zl8
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
udjoeib0s e2ds7p
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-3.3
k7y2z3s p8k
12 Jan 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
fwr7c4j po9s1a881
12 Jan 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.13
nrjvx8t16a25nszf6
12 Jan 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next